Synergistic Mechanisms of Selected Polyphenols in Overcoming Chemoresistance and Enhancing Chemosensitivity in Colorectal Cancer

Overview

Journal Antioxidants (Basel)

Date 2024 Jul 27

PMID 39061884

Authors

Kha Wai Hon

Rakesh Naidu

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is a leading cause of cancer deaths worldwide. Despite significant advances in medical treatment, chemotherapy as monotherapy can lead to substantial side effects and chemoresistance. This underscores the need for therapeutic approaches that are not only pharmacologically safe but also modulate multiple potent signaling pathways and sensitize cancer cells to overcome resistance to standard drugs. In recent years, scientists have been searching for natural compounds that can be used as chemosensitizers in addition to conventional medications for the synergistic treatment of CRC. Polyphenols represent a diverse group of natural compounds that can target multiple signaling pathways in cancer cells to induce anti-cancer effects. Additionally, polyphenols have been shown to work synergistically with chemotherapeutics and other natural compounds in cancer cells. This review aims to provide a comprehensive insight into the synergistic mechanisms of selected polyphenols as chemosensitizers in CRC cells. Further research and clinical trials are warranted to fully harness the synergistic mechanisms of selected polyphenols combined with chemotherapy or natural compounds in improving cancer treatment outcomes.

Citing Articles

Synergistic Combination of Quercetin and Mafosfamide in Treatment of Bladder Cancer Cells.

Spagnuolo C, Mautone F, Meola A, Moccia S, Di Lorenzo G, Buonerba C Molecules. 2024; 29(21).

PMID: 39519817 PMC: 11547860. DOI: 10.3390/molecules29215176.

Potential Strategies for Overcoming Drug Resistance Pathways Using Propolis and Its Polyphenolic/Flavonoid Compounds in Combination with Chemotherapy and Radiotherapy.

Orsolic N, Jazvinscak Jembrek M Nutrients. 2024; 16(21).

PMID: 39519572 PMC: 11547968. DOI: 10.3390/nu16213741.

References

Syu J, Chi J, Kung H . Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia. Oncotarget. 2016; 7(12):14659-72. PMC: 4924742. DOI: 10.18632/oncotarget.7406. View

Dmello R, To S, Chand A . Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer. Int J Mol Sci. 2021; 22(4). PMC: 7922123. DOI: 10.3390/ijms22042067. View

Parseghian C, Parikh N, Wu J, Jiang Z, Henderson L, Tian F . Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer. Clin Cancer Res. 2017; 23(15):4146-4154. PMC: 5540760. DOI: 10.1158/1078-0432.CCR-16-3138. View

Farsad-Naeimi A, Alizadeh M, Esfahani A, Aminabad E . Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients. Food Funct. 2018; 9(4):2025-2031. DOI: 10.1039/c7fo01898c. View

Chen Y, Wang X, Zhang Q, Zhu J, Li Y, Xie C . (-)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway. Nutrients. 2017; 9(6). PMC: 5490551. DOI: 10.3390/nu9060572. View

Mohapatra P, Preet R, Choudhuri M, Choudhuri T, Kundu C . 5-fluorouracil increases the chemopreventive potentials of resveratrol through DNA damage and MAPK signaling pathway in human colorectal cancer cells. Oncol Res. 2011; 19(7):311-21. DOI: 10.3727/096504011x13079697132844. View

Shi J, Ji X, Shan S, Zhao M, Bi C, Li Z . The interaction between apigenin and PKM2 restrains progression of colorectal cancer. J Nutr Biochem. 2023; 121:109430. DOI: 10.1016/j.jnutbio.2023.109430. View

Jain S, Lenaghan S, Dia V, Zhong Q . Co-delivery of curcumin and quercetin in shellac nanocapsules for the synergistic antioxidant properties and cytotoxicity against colon cancer cells. Food Chem. 2023; 428:136744. DOI: 10.1016/j.foodchem.2023.136744. View

Wolpin B, Meyerhardt J, Mamon H, Mayer R . Adjuvant treatment of colorectal cancer. CA Cancer J Clin. 2007; 57(3):168-85. DOI: 10.3322/canjclin.57.3.168. View

10.

Ganesan K, Jayachandran M, Xu B . Diet-Derived Phytochemicals Targeting Colon Cancer Stem Cells and Microbiota in Colorectal Cancer. Int J Mol Sci. 2020; 21(11). PMC: 7312951. DOI: 10.3390/ijms21113976. View

11.

Javed Z, Khan K, Herrera-Bravo J, Naeem S, Iqbal M, Sadia H . Genistein as a regulator of signaling pathways and microRNAs in different types of cancers. Cancer Cell Int. 2021; 21(1):388. PMC: 8296701. DOI: 10.1186/s12935-021-02091-8. View

12.

Darweesh R, El-Elimat T, Zayed A, Khamis T, Babaresh W, Arafat T . The effect of grape seed and green tea extracts on the pharmacokinetics of imatinib and its main metabolite, N-desmethyl imatinib, in rats. BMC Pharmacol Toxicol. 2020; 21(1):77. PMC: 7670682. DOI: 10.1186/s40360-020-00456-9. View

13.

Gbolahan O, ONeil B, McRee A, Sanoff H, Fallon J, Smith P . A phase I evaluation of the effect of curcumin on dose-limiting toxicity and pharmacokinetics of irinotecan in participants with solid tumors. Clin Transl Sci. 2022; 15(5):1304-1315. PMC: 9099132. DOI: 10.1111/cts.13250. View

14.

Pasello M, Giudice A, Scotlandi K . The ABC subfamily A transporters: Multifaceted players with incipient potentialities in cancer. Semin Cancer Biol. 2019; 60:57-71. DOI: 10.1016/j.semcancer.2019.10.004. View

15.

Kang K, Piao M, Hyun Y, Zhen A, Cho S, Ahn M . Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells. Exp Mol Med. 2019; 51(4):1-14. PMC: 6465248. DOI: 10.1038/s12276-019-0238-y. View

16.

Pommier Y . Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer. 2006; 6(10):789-802. DOI: 10.1038/nrc1977. View

17.

Lin Y, He Z, Ye J, Liu Z, She X, Gao X . Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer. Onco Targets Ther. 2020; 13:13023-13032. PMC: 7762435. DOI: 10.2147/OTT.S278013. View

18.

Aromokeye R, Si H . Combined Curcumin and Luteolin Synergistically Inhibit Colon Cancer Associated with Notch1 and TGF-β Signaling Pathways in Cultured Cells and Xenograft Mice. Cancers (Basel). 2022; 14(12). PMC: 9221484. DOI: 10.3390/cancers14123001. View

19.

Majumdar A, Banerjee S, Nautiyal J, Patel B, Patel V, Du J . Curcumin synergizes with resveratrol to inhibit colon cancer. Nutr Cancer. 2009; 61(4):544-53. PMC: 6370344. DOI: 10.1080/01635580902752262. View

20.

Suhail M, AlZahrani W, Shakil S, Tarique M, Tabrez S, Zughaibi T . Analysis of some flavonoids for inhibitory mechanism against cancer target phosphatidylinositol 3-kinase (PI3K) using computational tool. Front Pharmacol. 2023; 14:1236173. PMC: 10612336. DOI: 10.3389/fphar.2023.1236173. View